Health Care

Manufacturers of health care equipment and devices. Includes medical instruments, drug delivery systems, cardiovascular & orthopedic devices, and diagnostic equipment.

Manufacturers of health care supplies and medical products not classified elsewhere. Includes eye care products, hospital supplies, and safety needle & syringe devices.

Distributors and wholesalers of health care products not classified elsewhere.

Providers of patient health care services not classified elsewhere. Includes dialysis centers, lab testing services, and pharmacy management services. Also includes companies providing business support services to health care providers, such as clerical support services, collection agency services, staffing services and outsourced sales & marketing services.

Owners and operators of health care facilities, including hospitals, nursing homes, rehabilitation and retirement centers and animal hospitals.
Owners and operators of Health Maintenance Organizations (HMOs) and other managed plans.

Companies providing information technology services primarily to health care providers. Includes companies providing application, systems and/or data processing software, internet-based tools, and IT consulting services to doctors, hospitals or businesses operating primarily in the Health Care sector.

Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.

Companies engaged in the research, development or production of pharmaceuticals. Includes veterinary drugs.

Companies enabling the drug discovery, development and production continuum by providing analytical tools, instruments, consumables & supplies, clinical trial services and contract research services. Includes firms primarily servicing the pharmaceutical
and biotechnology industries.

Profit & Loss

$ 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue 19,064,123,000 15,982,643,000 14,672,271,000 13,456,671,000 12,044,943,000 5,017,720,000 4,200,525,000 3,913,475,000 3,484,073,000 3,345,616,000
Cost of Goods Sold -6,083,531,000 -5,041,773,000 -4,756,488,000 -4,449,811,000 -4,149,808,000 -811,666,000 -650,956,000 -596,973,000 -525,231,000 -1,522,717,000
Gross Profit 12,980,592,000 10,940,870,000 9,915,783,000 9,006,860,000 7,895,135,000 4,206,054,000 3,549,569,000 3,316,502,000 2,958,842,000 1,822,899,000
Operating Costs -7,929,480,000 -7,412,456,000 -6,603,463,000 -5,931,135,000 -5,482,356,000 -3,541,272,000 -3,030,326,000 -2,740,826,000 -2,450,455,000 -1,328,007,000
Operating Profit 5,051,112,000 3,528,414,000 3,312,320,000 3,075,725,000 2,412,779,000 664,782,000 519,243,000 575,676,000 508,387,000 494,892,000
Financing Costs -259,419,000 -256,651,000 -248,963,000 -177,544,000 -147,236,000 -67,137,000 -55,928,000 -60,710,000 -65,147,000 -76,964,000
Profit Before Tax 4,791,693,000 3,271,763,000 3,063,357,000 2,898,181,000 2,265,543,000 597,645,000 463,315,000 514,966,000 443,240,000 417,928,000
Income Tax -1,069,035,000 -627,360,000 -585,588,000 -684,216,000 -485,723,000 -131,644,000 -109,278,000 -126,106,000 -103,572,000 -100,243,000
Profit 3,722,658,000 2,644,403,000 2,477,769,000 2,213,965,000 1,779,820,000 466,001,000 354,037,000 388,860,000 339,668,000 317,685,000

Balance Sheet

$ 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Current Assets 9,674,273,000 8,901,305,000 7,293,284,000 6,225,409,000 5,904,543,000 1,136,753,000 1,019,702,000 913,019,000 852,465,000 714,756,000
Non-Current Assets 20,243,618,000 18,690,525,000 14,980,950,000 12,750,025,000 11,096,322,000 6,233,866,000 5,329,003,000 4,884,587,000 4,665,761,000 4,214,049,000
Total Assets 29,917,891,000 27,591,830,000 22,274,234,000 18,975,434,000 17,000,865,000 7,370,619,000 6,348,705,000 5,797,606,000 5,518,226,000 4,928,805,000
Current Liabilities 5,321,537,000 4,211,633,000 4,037,584,000 2,782,563,000 3,231,748,000 1,220,439,000 588,306,000 1,021,194,000 1,024,639,000 981,435,000
Non-Current Liabilities 9,710,711,000 11,188,299,000 7,493,484,000 7,830,046,000 6,679,187,000 2,417,471,000 2,434,401,000 1,667,418,000 1,575,486,000 1,337,171,000
Total Liabilities 15,032,248,000 15,399,932,000 11,531,068,000 10,612,609,000 9,910,935,000 3,637,910,000 3,022,707,000 2,688,612,000 2,600,125,000 2,318,606,000
Total Equity 14,885,643,000 12,191,898,000 10,743,166,000 8,362,825,000 7,089,930,000 3,732,709,000 3,325,998,000 3,108,994,000 2,918,101,000 2,610,199,000

Cash Flow

$ 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Cash Flow from Operating Activities 5,664,736,000 3,848,598,000 2,491,708,000 2,670,020,000 1,982,965,000 707,708,000 512,084,000 556,358,000 459,459,000 486,758,000
Cash Flow from Investing Activities -2,059,950,000 -1,701,617,000 -2,386,629,000 -1,998,536,000 -1,536,392,000 -786,237,000 -288,989,000 -339,370,000 -258,584,000 -335,736,000
Cash Flow from Financing Activities -3,356,458,000 -1,179,436,000 196,166,000 -804,919,000 -14,942,000 131,849,000 -219,347,000 -210,280,000 -175,151,000 -154,112,000
Net Change in Cash 248,328,000 967,545,000 301,245,000 -133,435,000 431,631,000 53,320,000 3,748,000 6,708,000 25,724,000 -3,090,000
Cash at Beginning 2,381,449,000 1,394,446,000 1,125,968,000 1,280,617,000 845,736,000 249,393,000 232,137,000 219,729,000 168,594,000 174,687,000
Exchange Fluctuations 150,000 19,458,000 -32,767,000 -21,214,000 3,250,000 -12,277,000 13,508,000 5,700,000 25,411,000 -3,003,000
Cash at End of Period 2,629,927,000 2,381,449,000 1,394,446,000 1,125,968,000 1,280,617,000 290,436,000 249,393,000 232,137,000 219,729,000 168,594,000

Profitability

  2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Gross Margin 68.1% 68.5% 67.6% 66.9% 65.5% 83.8% 84.5% 84.7% 84.9% 54.5%
Operating Margin 26.5% 22.1% 22.6% 22.9% 20.0% 13.2% 12.4% 14.7% 14.6% 14.8%
Profit Margin 19.5% 16.5% 16.9% 16.5% 14.8% 9.3% 8.4% 9.9% 9.7% 9.5%

Management Effectiveness

  2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Return on Assets 12.4% 9.6% 11.1% 11.7% 10.5% 6.3% 5.6% 6.7% 6.2% 6.4%
Return on Equity 25.0% 21.7% 23.1% 26.5% 25.1% 12.5% 10.6% 12.5% 11.6% 12.2%
Current Ratio 1.82 2.11 1.81 2.24 1.83 0.93 1.73 0.89 0.83 0.73
Debt to Equity Ratio 1.01 1.26 1.07 1.27 1.40 0.97 0.91 0.86 0.89 0.89

Valuation

  2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Share Price ($) 158.78 155.80 118.94 111.23 83.36 21.55 21.37 17.33 14.81 12.70
Shares on Issue 933,047,064 929,225,088 927,095,036 877,105,775 872,650,218 415,089,808 401,991,556 400,811,556 397,158,181 390,969,875
Market Capitalisation ($) 148,150,173,968 144,771,596,183 110,269,024,428 97,559,452,443 72,743,214,993 8,945,185,362 8,590,559,552 6,946,064,265 5,881,912,661 4,965,317,413
Revenue per Share ($) 20.43 17.20 15.83 15.34 13.80 12.09 10.45 9.76 8.77 8.56
Earnings per Share ($) 3.99 2.85 2.67 2.52 2.04 1.12 0.88 0.97 0.86 0.81
Dividends per Share ($) 1.48 1.39 1.27 1.04 1.01 0.53 0.70 0.65 0.52 0.59
Dividend Yield 0.9% 0.9% 1.1% 0.9% 1.2% 2.5% 3.3% 3.7% 3.5% 4.7%
Price to Sales Ratio 7.8 9.1 7.5 7.2 6.0 1.8 2.0 1.8 1.7 1.5
Price to Earnings Ratio 39.8 54.7 44.5 44.1 40.9 19.2 24.3 17.9 17.3 15.6
Price to Book Ratio 10.0 11.9 10.3 11.7 10.3 2.4 2.6 2.2 2.0 1.9

All Companies in the Health Care Sector

Alphabetic by Name